E.R. SAGITOVA, O.N. KRAVCOVA

 Orenburg State Medical University, Orenburg

 Contact details:

Sagitova E.R. — PhD (medicine), Associate Professor of the Department of Polyclinic Therapy

Address: 6 Sovetskaya St., Orenburg, Russian Federation, 460000, tel.: +7-912-354-53-81, e-mail: sagel.8181@mail.ru

SARS-CoV-2 is a rather insidious disease that affects various organs and systems, including the musculoskeletal system. The interest of scientists and doctors is attracted by the condition of patients who have had a coronavirus infection and faced new symptoms. During the pandemic, many medical problems were revealed, which are associated with the relations between the viral infection and immune-inflammatory rheumatic diseases, such as rheumatoid arthritis, sero-negative spondylarthritis, psoriasic and gouty arthritis, systemic diseases of connective tissues. The article describes a clinical case of ankylosing spondylitis that developed after a coronavirus infection in a 59-year-old patient. The infection turns out to be a provoking mechanism for the evolution of immune-inflammatory diseases of the joints, which include Bechterew’s disease.

Key words: ankylosing spondylitis, coronavirus infection COVID-19, SARS-CoV-2, polymerase chain reaction, osteoartitis, sacroiliitis.

REFERENCES

1. Akhunova R.R., Akhunova G.R. Ankylosing spondylitis: a description of a clinical case from the standpoint of the international classification of functioning, disability and health. Klinitsist, 2019, no. 13 (3–4), pp. 67–73 (in Russ.). DOI: 1.10.17650/1818-8338-2019-13-3-4-67-73
2. Rumyantseva D.G., Podryadnova M.V., Rumyantseva O.A. et al. Severe course of ankylosing spondylitis with resistance to drug therapy. Nauchno-prakticheskaya revmatologiya, 2020, no. 58 (2), pp. 233–237 (in Russ.). DOI: 2.10.14412/1995-4484-2020-233-237
3. Nasonov E.L. Immunopathology and immunopharmacotherapy of coronavirus disease 2019 (COVID-19): focus on interleukin 6. Nauchno-prakticheskaya revmatologiya, 2020, no. 58 (3), pp. 245–261 (in Russ.). DOI: 10.14412/1995-4484-2020-245-261
4. Rumyantseva D.G., Urumova M.M., Erdes Sh.F. New coronavirus infection COVID-19 as a trigger for the development of symptoms of ankylosing spondylitis. Clinical observation. Terapevticheskiy arkhiv, 2021, no. 93 (5), pp. 609–612 (in Russ.). DOI: 10.26442/00403660.2021.05.200793
5. Kravtsova O.N., Bagirova G.G. The many-faced coronavirus. Vrach, 2021, no. 32 (5), pp. 5–11 (in Russ.), available at: https://doi.org/10.29296/25877305-2021-05-01″5 DOI:10.29296/25877305-2021-05-01
6. Belov B.S., Murav’eva N.V., Tarasova G.M. COVID-19 and rheumatology: so far, so close. Meditsinskiy sovet, 2020, no. 8, pp. 135–143 (in Russ.). DOI: 10.21518/2079-701X-2020-8-135-143
7. Belov B.S., Lila A.M. COVID-19 and rheumatology: a year later. Nauchno-prakticheskaya revmatologiya, 2021, no. 59 (1), pp. 31–36 (in Russ.), avaialble at: https://rsp.mediar-press.net/rsp/article/view/2987. DOI: 10.47360/1995-4484-2021-31-36
8. Ono K., Kishimoto M., Shimasaki T. et al. Reactive arthritis after COVID-19 infection. RMD Open, 2020, vol. 6, p. e001350. DOI: 10.1136/ rmdopen-2020-001350
9. https://onlinelibrary.wiley.com/action/doSearch?ContribAuthorRaw=Hasanoglu%2C+Imran Guner The first reactive arthritis case associated with COVID‐19. Journal of Medical Virology, 2021, vol. 93, pp. 192–193. DOI: 10.1002/jmv.26296
10. Danssaert Z., Raum G., Hemtasilpa S. Reactive Arthritis in a 37-Year-Old Female with SARS-CoV2 Infection. Cureus Journal of Medical Science, 2020, vol. 12 (8), p. e9698. DOI: 10.7759/cureus.9698